+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 20Years - 60Years
FEMALE
Healthy Volunteers
ID07306247

Study of ALA Photodynamic Therapy Compared to Observation for Cervical LSIL with HPV1618 Infection in Women

Led by Second Affiliated Hospital, Zhejiang University, School of Medicine · Updated on 2026-10-16

225

Participants Needed

5

Research Sites

47 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of ALA-PDT a type of photodynamic therapy compared to observation for treating cervical low-grade squamous intraepithelial lesions LSIL in women infected with HPV types 16 or 18. This prospective, multicenter trial aims to assess the effectiveness and safety of ALA-PDT in this condition. The study also monitors HPV clearance, lesion progression, and patient quality of life. Participants in the treatment group receive ALA-PDT applied to the cervix and cervical canal, followed by light therapy every 7 to 14 days for a total of 3 to 6 sessions. The comparison group undergoes observation and follow-up without active treatment. Both groups are followed over time to evaluate lesion regression and HPV clearance rates. During the study, women will have assessments including colposcopy-guided cervical biopsies to track lesion changes and HPV status over up to two years. Researchers will also monitor safety, tolerability, patient-reported quality of life, and treatment satisfaction. The primary outcome is the rate of cervical lesion regression at 6 months, with additional outcomes measured up to 2 years. The total participation duration extends through the follow-up period until study completion.

CONDITIONS

Brief Title

Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection

Research Team

X

Xiaoyun Wang, Doctor

J

Jianwei Zhou, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here